Bain Capital Public Equity Management as of March 31, 2018
Portfolio Holdings for Bain Capital Public Equity Management
Bain Capital Public Equity Management holds 58 positions in its portfolio as reported in the March 2018 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Altaba | 18.0 | $306M | 4.1M | 74.04 | |
| Citrix Systems | 12.5 | $212M | 685k | 309.83 | |
| Ball Corporation (BALL) | 11.1 | $189M | 1.4M | 132.40 | |
| Honeywell International (HON) | 4.8 | $83M | 571k | 144.51 | |
| Mulesoft Inc cl a | 4.0 | $67M | 1.5M | 43.98 | |
| Northrop Grumman Corporation (NOC) | 3.6 | $61M | 176k | 349.12 | |
| Hilton Worldwide Holdings (HLT) | 3.6 | $61M | 775k | 78.76 | |
| Vertex Pharmaceuticals Incorporated (VRTX) | 3.3 | $56M | 91k | 620.00 | |
| Gartner (IT) | 3.2 | $54M | 462k | 117.62 | |
| Godaddy Inc cl a (GDDY) | 2.9 | $50M | 810k | 61.42 | |
| Coca Cola European Partners (CCEP) | 2.6 | $45M | 1.1M | 41.66 | |
| New York Times Company (NYT) | 2.1 | $35M | 1.5M | 24.10 | |
| Iqvia Holdings (IQV) | 1.9 | $33M | 332k | 98.11 | |
| CSX Corporation (CSX) | 1.8 | $31M | 558k | 55.71 | |
| Fortive (FTV) | 1.7 | $29M | 379k | 77.52 | |
| Nxp Semiconductors N V (NXPI) | 1.7 | $28M | 242k | 117.00 | |
| Boeing Company (BA) | 1.3 | $23M | 69k | 327.88 | |
| AstraZeneca (AZN) | 1.3 | $23M | 646k | 34.97 | |
| AutoZone (AZO) | 1.1 | $19M | 30k | 648.71 | |
| Wright Express (WEX) | 1.0 | $18M | 112k | 156.62 | |
| Comcast Corporation (CMCSA) | 0.9 | $16M | 468k | 34.17 | |
| Avexis | 0.9 | $15M | 120k | 123.58 | |
| Cloudera | 0.9 | $15M | 687k | 21.58 | |
| Signature Bank (SBNY) | 0.8 | $14M | 99k | 141.95 | |
| O'reilly Automotive (ORLY) | 0.8 | $13M | 53k | 247.38 | |
| Eaton (ETN) | 0.8 | $13M | 165k | 79.91 | |
| Liberty Media Corp Series C Li | 0.8 | $13M | 411k | 30.85 | |
| Halliburton Company (HAL) | 0.7 | $12M | 263k | 46.94 | |
| Planet Fitness Inc-cl A (PLNT) | 0.7 | $12M | 323k | 37.77 | |
| Essent (ESNT) | 0.7 | $12M | 281k | 42.56 | |
| Umpqua Holdings Corporation | 0.7 | $11M | 518k | 21.41 | |
| Alexion Pharmaceuticals | 0.6 | $11M | 57k | 182.22 | |
| Worldpay Ord | 0.6 | $9.3M | 114k | 82.24 | |
| E TRADE Financial Corporation | 0.5 | $9.1M | 164k | 55.41 | |
| WisdomTree Investments (WT) | 0.5 | $8.6M | 943k | 9.17 | |
| Pentair cs (PNR) | 0.5 | $8.4M | 123k | 68.13 | |
| Rh (RH) | 0.5 | $7.9M | 82k | 95.29 | |
| Guess? (GES) | 0.5 | $7.7M | 372k | 20.74 | |
| Allegheny Technologies Incorporated (ATI) | 0.5 | $7.7M | 326k | 23.68 | |
| Hldgs (UAL) | 0.5 | $7.6M | 110k | 69.47 | |
| ICICI Bank (IBN) | 0.4 | $6.9M | 780k | 8.85 | |
| BioMarin Pharmaceutical (BMRN) | 0.4 | $7.0M | 86k | 81.08 | |
| Affimed Therapeutics B V | 0.3 | $5.9M | 3.2M | 1.85 | |
| Merck & Co (MRK) | 0.3 | $5.7M | 125k | 45.36 | |
| Immune Design | 0.3 | $5.5M | 1.7M | 3.30 | |
| Ironwood Pharmaceuticals (IRWD) | 0.3 | $4.5M | 292k | 15.43 | |
| Gilead Sciences (GILD) | 0.2 | $4.2M | 56k | 75.40 | |
| Clovis Oncology | 0.2 | $2.8M | 53k | 52.80 | |
| Array BioPharma | 0.1 | $2.5M | 153k | 16.32 | |
| Medicines Company | 0.1 | $1.9M | 57k | 32.94 | |
| Proteostasis Therapeutics In | 0.1 | $1.9M | 400k | 4.75 | |
| Exelixis (EXEL) | 0.1 | $1.7M | 78k | 22.15 | |
| Amgen (AMGN) | 0.1 | $917k | 865.00 | 1060.12 | |
| Ardagh Group S A cl a | 0.1 | $912k | 49k | 18.68 | |
| Bristol Myers Squibb (BMY) | 0.0 | $522k | 3.3k | 160.67 | |
| Curis | 0.0 | $375k | 577k | 0.65 | |
| GlaxoSmithKline | 0.0 | $140k | 7.0k | 20.00 | |
| Aeglea Biotherapeutics | 0.0 | $95k | 9.6k | 9.89 |
